Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(NY: MSOX )

0.6621 -0.0255 (-3.71%)
Streaming Delayed Price Updated: 11:13 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about MSOX

AdvisorShares Announces Reverse Split For MSOS Daily Leveraged ETF, What Investors Need To Know
AdvisorShares announces a 1-for-20 reverse split for its MSOS Daily Leveraged ETF (MSOX), impacting share count without changing value. 
Via Benzinga
Topics ETFs
AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest
AdvisorShares MSOS ETF surges 8% as U.S. cannabis reform nears. Explore key investment signals and market opportunities. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
New SEC Filings Reveal Major Risks In Cannabis ETFs Following Recent Volatility — But There's Still Room for Optimism
Cannabis ETFs MSOS and MSOX facing regulatory uncertainty and market downturn, with potential for rebound if federal law is amended. 
Via Benzinga
Topics Cannabis ETFs Regulatory Compliance
Exposures Cannabis Legal Regulatory
Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana
The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration's (DEA) historic decision to align its stance with a recommendation from the Department of Health and... 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
There Is No Comparison Between These 9 Cannabis ETFs
This article discusses the cannabis industry and the 9 cannabis ETFs that are available. 
Via Talk Markets
Topics Cannabis ETFs
Exposures Cannabis
Dazed By The Cannabis ETF Whirlwind? Here Is A Short Guide To Survival
Explore the volatile cannabis ETFs market, trends, disparities, and the future landscape. Expert insights reveal investment strategies. 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Cannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industry
Cannabis stocks and ETFs opened higher on Tuesday following the release of documents related to the Department of Health and Human Service's (HHS) review of cannabis. Investors are optimistic about... 
Via Benzinga
Topics Cannabis ETFs
Exposures Cannabis
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning! 
Via InvestorPlace
5 Top-Performing Leveraged ETFs Of Blockbuster November
Here is a bunch of the best-performing leveraged equity ETFs from different corners of the market that are leaders in their segments. 
Via Talk Markets
Topics ETFs
U.S. Cannabis: Growth At A Reasonable Price?
By Todd Harrison via Cannabis Confidential (Nov 14) 
Via Benzinga
Topics Cannabis
Exposures Cannabis
5 Leveraged/Inverse ETFs That Gained More Than 40% In Q3
The third quarter proved to be highly volatile and uncertain for the U.S. stock market. This has resulted in huge demand for leveraged or inverse-leveraged ETFs as these fetch outsized returns on quick... 
Via Talk Markets
Topics ETFs
Federal Agency Gives Green Light: How Relaxed Marijuana Laws Could Boost U.S. Stocks
The weekend was abuzz with anticipation after the HHS recommended to reschedule cannabis last Wednesday. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
5 Best Leveraged ETFs Of November
Here are the best-performing leveraged equity ETFs from different corners of the market that gained more than 25% in November. 
Via Talk Markets
AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2X Daily ETF MSOX
AdvisorShares revealed that the AdvisorShares MSOS 2x Daily ETF (ARCA:MSOX) will begin trading on August 24th. 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.